Significance of TP53, CDKN2A, SMAD4 and KRAS in Pancreatic Cancer
Related Posts
Bransky NP, Walling AM, Klomhaus AM, Glaspy JA, Garcia-Jimenez MD. Racial/Ethnic Disparities in Oncology Clinical Trial Participation: Investigator Attitudes, Needs, and Motivation to Improve. JCO[...]
Lurain K, El Zarif T, Ramaswami R, Nassar AH, Adib E, Abdel-Wahab N, Chintapally N, Drolen CE, Feldman T, Haykal T, Nebhan CA, Kambhampati S,[...]
Varuzhanyan G, Chen CC, Freeland J, He T, Tran W, Song K, Wang L, Cheng D, Xu S, Dibernardo GA, Esedebe FN, Bhatia V, Han[...]